DK1037968T4 - Matrixgranule - Google Patents

Matrixgranule Download PDF

Info

Publication number
DK1037968T4
DK1037968T4 DK98964823.3T DK98964823T DK1037968T4 DK 1037968 T4 DK1037968 T4 DK 1037968T4 DK 98964823 T DK98964823 T DK 98964823T DK 1037968 T4 DK1037968 T4 DK 1037968T4
Authority
DK
Denmark
Prior art keywords
protein
granules
matrix
sugar
core
Prior art date
Application number
DK98964823.3T
Other languages
English (en)
Other versions
DK1037968T3 (da
Inventor
Thomas S Green
Nathaniel T Becker
Robert I Christensen Jr
Original Assignee
Genencor Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26803043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1037968(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genencor Int filed Critical Genencor Int
Publication of DK1037968T3 publication Critical patent/DK1037968T3/da
Application granted granted Critical
Publication of DK1037968T4 publication Critical patent/DK1037968T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/98—Preparation of granular or free-flowing enzyme compositions

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Luminescent Compositions (AREA)
  • Glass Compositions (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Housing For Livestock And Birds (AREA)
  • Overhead Projectors And Projection Screens (AREA)
DK98964823.3T 1997-12-20 1998-12-18 Matrixgranule DK1037968T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99545797A 1997-12-20 1997-12-20
US10587498P 1998-10-27 1998-10-27
PCT/US1998/027119 WO1999032613A1 (en) 1997-12-20 1998-12-18 Matrix granule

Publications (2)

Publication Number Publication Date
DK1037968T3 DK1037968T3 (da) 2007-02-05
DK1037968T4 true DK1037968T4 (da) 2014-03-10

Family

ID=26803043

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98964823.3T DK1037968T4 (da) 1997-12-20 1998-12-18 Matrixgranule

Country Status (14)

Country Link
EP (1) EP1037968B2 (da)
JP (1) JP2001526887A (da)
KR (1) KR20010040305A (da)
CN (1) CN1242060C (da)
AT (1) ATE341619T1 (da)
AU (1) AU752879B2 (da)
BR (1) BR9813766A (da)
CA (1) CA2313168A1 (da)
CZ (1) CZ302332B6 (da)
DE (1) DE69836098T3 (da)
DK (1) DK1037968T4 (da)
NZ (1) NZ505300A (da)
PL (1) PL342710A1 (da)
WO (1) WO1999032613A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999032613A1 (en) * 1997-12-20 1999-07-01 Genencor International, Inc. Matrix granule
US6423517B2 (en) 1997-12-20 2002-07-23 Genecor International, Inc. Granule containing protein and salt layered on an inert particle
WO1999032595A1 (en) 1997-12-20 1999-07-01 Genencor International, Inc. Granule with hydrated barrier material
CA2326183A1 (en) * 1998-04-02 1999-10-14 Genencor International, Inc. Modified starch coating
US7662409B2 (en) 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
DE69924276T2 (de) 1998-10-27 2006-05-11 Genencor International, Inc., Palo Alto Matrixgranulat
CA2348896A1 (en) 1998-11-13 2000-05-25 Douglas A. Dale Fluidized bed low density granule
EP1149151B1 (en) 1999-01-08 2006-03-29 Genencor International, Inc. Low-density compositions and particulates including same
JP2003514922A (ja) 1999-10-15 2003-04-22 ジェネンコア インターナショナル インコーポレーテッド 蛋白質含有顆粒および顆粒配合物
CA2426809C (en) 2000-10-27 2009-11-03 Genencor International, Inc. Particle with substituted polyvinyl alcohol coating
EP1372713A4 (en) * 2001-04-02 2010-01-13 Genencor Int GRANULATE WITH REDUCED DUST POTENTIAL
US8076113B2 (en) 2001-04-02 2011-12-13 Danisco Us Inc. Method for producing granules with reduced dust potential comprising an antifoam agent
US7018821B2 (en) 2001-06-22 2006-03-28 Genencor International, Inc. Highly impact-resistant granules
US8623393B2 (en) 2002-04-29 2014-01-07 Gel-Del Technologies, Inc. Biomatrix structural containment and fixation systems and methods of use thereof
WO2004010930A2 (en) * 2002-07-30 2004-02-05 Genencor International, Inc. Reduced aerosol generating formulations
US8465537B2 (en) 2003-06-17 2013-06-18 Gel-Del Technologies, Inc. Encapsulated or coated stent systems
EP1660013A4 (en) 2003-08-26 2011-07-20 Gel Del Technologies Inc BIOMATERIAL AND PROTEIN BIOCOACERVATES, METHODS OF MAKING AND USING THEM
WO2005055945A2 (en) 2003-12-08 2005-06-23 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
DE102006053071A1 (de) * 2006-11-10 2008-05-15 Ab Enzymes Gmbh Protein-enthaltender Stoff mit erhöhter Temperaturstabilität
EP2237770A4 (en) 2007-12-26 2011-11-09 Gel Del Technologies Inc BIOCOMPATIBLE PROTEIN PARTICLES, PARTICLE DEVICES AND METHODS THEREOF
US20110065163A1 (en) * 2008-02-14 2011-03-17 Becker Nathaniel T Small Enzyme-Containing Granules
DK2285823T4 (da) * 2008-06-09 2024-05-21 Danisco Us Inc Genvinding af uopløseligt enzym fra gæringsbouillon og formulering af uopløseligt enzym
US10016534B2 (en) 2008-11-17 2018-07-10 Gel-Del Technologies, Inc. Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
WO2011090980A1 (en) 2010-01-20 2011-07-28 Danisco Us Inc. Mold treatment
EP2596092B2 (en) 2010-07-20 2020-04-01 The Procter and Gamble Company Particles with a plurality of coatings
AR083328A1 (es) * 2010-07-20 2013-02-21 Procter & Gamble Particula de suministro
WO2016149636A1 (en) 2015-03-19 2016-09-22 Danisco Us Inc Stable granules with low internal water activity
DE102015217816A1 (de) 2015-09-17 2017-03-23 Henkel Ag & Co. Kgaa Verwendung hochkonzentrierter Enzymgranulate zur Erhöhung der Lagerstabilität von Enzymen
KR102555664B1 (ko) * 2017-02-21 2023-07-18 이에이 파마 가부시키가이샤 과립 제제
ES2938609T3 (es) 2017-09-20 2023-04-13 Tillotts Pharma Ag Preparación de formas farmacéuticas sólidas que comprenden anticuerpos mediante estratificación de solución/suspensión
EP3844255A1 (en) 2018-08-30 2021-07-07 Danisco US Inc. Enzyme-containing granules
WO2023039270A2 (en) 2021-09-13 2023-03-16 Danisco Us Inc. Bioactive-containing granules

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1590432A (en) 1976-07-07 1981-06-03 Novo Industri As Process for the production of an enzyme granulate and the enzyme granuate thus produced
NZ208612A (en) 1983-06-24 1991-09-25 Genentech Inc Method of producing "procaryotic carbonyl hydrolases" containing predetermined, site specific mutations
US4760025A (en) 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
US5185258A (en) 1984-05-29 1993-02-09 Genencor International, Inc. Subtilisin mutants
JPS6192570A (ja) 1984-10-12 1986-05-10 Showa Denko Kk 酵素造粒法
US4689297A (en) 1985-03-05 1987-08-25 Miles Laboratories, Inc. Dust free particulate enzyme formulation
EP0272923A3 (en) * 1986-12-24 1989-08-16 Stabra AG Particulate product including glucose oxidase
DK435687D0 (da) * 1987-08-21 1987-08-21 Novo Industri As Enzymholdigt granulat og fremgangsmaade til fremstilling deraf
GB8816443D0 (en) * 1988-07-11 1988-08-17 Albright & Wilson Liquid enzymatic detergents
DE3811659C1 (da) * 1988-04-07 1989-11-16 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De
EP0506791B1 (en) 1989-12-21 1993-09-08 Novo Nordisk A/S Enzyme containing preparation and detergent containing such preparation
US5814501A (en) * 1990-06-04 1998-09-29 Genencor International, Inc. Process for making dust-free enzyme-containing particles from an enzyme-containing fermentation broth
US5254283A (en) 1991-01-17 1993-10-19 Genencor International, Inc. Isophthalic polymer coated particles
JPH04271785A (ja) * 1991-02-28 1992-09-28 Kao Corp 酵素固形製剤及びその製造方法
US5879920A (en) * 1991-10-07 1999-03-09 Genencor International, Inc. Coated enzyme-containing granule
US5324649A (en) 1991-10-07 1994-06-28 Genencor International, Inc. Enzyme-containing granules coated with hydrolyzed polyvinyl alcohol or copolymer thereof
EP0656058B1 (de) * 1992-08-14 1997-12-10 Genencor International GmbH Neue enzymgranulate
DE69632638T2 (de) 1995-10-06 2004-11-11 Genencor International, Inc., Palo Alto Mikrogranulaten zur nahrungs- oder futteranwendung
WO1999032613A1 (en) * 1997-12-20 1999-07-01 Genencor International, Inc. Matrix granule

Also Published As

Publication number Publication date
EP1037968A1 (en) 2000-09-27
DK1037968T3 (da) 2007-02-05
AU752879B2 (en) 2002-10-03
CZ302332B6 (cs) 2011-03-16
ATE341619T1 (de) 2006-10-15
DE69836098T2 (de) 2007-05-03
CN1242060C (zh) 2006-02-15
CN1282370A (zh) 2001-01-31
CA2313168A1 (en) 1999-07-01
NZ505300A (en) 2002-12-20
JP2001526887A (ja) 2001-12-25
AU2006199A (en) 1999-07-12
DE69836098D1 (de) 2006-11-16
DE69836098T3 (de) 2014-04-30
PL342710A1 (en) 2001-07-02
BR9813766A (pt) 2000-10-24
EP1037968B2 (en) 2014-02-05
KR20010040305A (ko) 2001-05-15
EP1037968B1 (en) 2006-10-04
WO1999032613A1 (en) 1999-07-01
CZ20002307A3 (cs) 2000-12-13

Similar Documents

Publication Publication Date Title
DK1037968T3 (da) Matrixgranule
DE69924276D1 (de) Matrixgranulat
WO1999000010A3 (en) TRANSGENIC ANIMALS EXPRESSING HUMAN Fc RECEPTORS
NZ504114A (en) Vitamin k-dependent polypeptides such as protein C where substitution at amino acid sites 11, 12, 29, 33 or 34 affects membrane binding affinity of the protein and ultimately blood clotting ability
PT1053256E (pt) Anticorpos para o receptor de morte 4 (dr4) e utilizações destes
ATE375365T1 (de) Antikörper varianten und fragmente davon
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
ATE343378T1 (de) Biologisch abbaubares alginatgel mit verzögerter freisetzung
DK1051174T3 (da) Gastrobeskyttede omeprazolmikrogranula, fremgangsmåde til opnåelse deraf og farmaceutiske præparater
ATE153829T1 (de) Wasserdispergierbare granulate von flussigen pestiziden.
IL134862A0 (en) dsRNA/dsRNA-BINDING PROTEIN METHODS AND COMPOSITIONS
EP0979656A3 (en) Composition containing radioisotopes immobilised on solid particles, and its use in brachytherapy
DE69725754D1 (de) Eingekapselte Antikörper-produzierende Zellen
WO2000034447A3 (en) Human ubiquitin ligase e3 for the modulation of nf-kappa b
WO2000018909A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM)
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
GB9811221D0 (en) Bacterial-pheromones and uses therefor
ATE141522T1 (de) Flussiger biologischer kleber
WO2004084800A3 (en) A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use
AU7478098A (en) Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
Murphy et al. A comparison of the effects of prior cold incubation on cerebral cortex function in a hibernator (Cricetus auratus) and a non-hibernator (Cavia porcellus)--I. Oxygen consumption in cerebral cortex slices after in vitro cold incubation
WO1999024052A3 (en) Use of protein h as cytostatic agent
朱仁华 Components of Decellwall Enzymes of Three Sea Snails——Other Carbohydrases
AU2002300605A1 (en) Compositions Comprising Conjugates of Stable, Active, Human OB Protein with Antibody FC Chain and Methods
AU708825C (en) Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody